2 Cancer-Focused Stocks That Could Soar, According to Wall Street
Patience is a virtue, or so says an old proverb. That sentiment certainly applies to the stock market. The longer one holds shares of great companies, the greater the potential for compounding to work its magic. That's why the buy and hold strategy works. However, it can be tough to find quality stocks worth holding onto.
If you need some inspiration, here are two cancer-focused companies that could provide excellent returns in the coming years: Exact Sciences (NASDAQ: EXAS) and Guardant Health (NASDAQ: GH). Although both companies have lagged the market recently, they boast substantial upside potential if we go by price targets set by Wall Street analysts. Here's the rundown.
Source Fool.com